tiprankstipranks
Advertisement
Advertisement

CMPX Stock Latest News

Compass Showcases Promising Tovecimig Data, Eyes Commercialization
Company AnnouncementsCompass Showcases Promising Tovecimig Data, Eyes Commercialization
20d ago
8K
CMPX
Compass Therapeutics Adopts Second Amended and Restated Bylaws
PremiumCompany Announcements
Compass Therapeutics Adopts Second Amended and Restated Bylaws
28d ago
8K
CMPX
Compass Therapeutics Shareholders Back Directors, Pay, Auditor Oversight
PremiumCompany Announcements
Compass Therapeutics Shareholders Back Directors, Pay, Auditor Oversight
1M ago
8K
CMPX
Compass Therapeutics Maintained at Buy as Analyst Cites Promising CTX-8371 Data and Reaffirms $24 Price Target
PremiumRatings
Compass Therapeutics Maintained at Buy as Analyst Cites Promising CTX-8371 Data and Reaffirms $24 Price Target
2M ago
CMPX
Compass Therapeutics: Buy Rating Reiterated as Clinical Progress Strengthens Approval Odds; $6 Price Target Maintained
PremiumRatings
Compass Therapeutics: Buy Rating Reiterated as Clinical Progress Strengthens Approval Odds; $6 Price Target Maintained
3M ago
CMPX
Compass Therapeutics reports Q1 EPS (10c), consensus (10c)
PremiumThe FlyCompass Therapeutics reports Q1 EPS (10c), consensus (10c)
3M ago
CMPX
Micron initiated, Rambus downgraded: Wall Street’s top analyst calls
Premium
The Fly
Micron initiated, Rambus downgraded: Wall Street’s top analyst calls
3M ago
MU
TU
Compass Therapeutics price target lowered to $7 from $13 at Canaccord
Premium
The Fly
Compass Therapeutics price target lowered to $7 from $13 at Canaccord
3M ago
CMPX
Compass Therapeutics downgraded to Market Perform from Outperform at Raymond James
PremiumThe Fly
Compass Therapeutics downgraded to Market Perform from Outperform at Raymond James
3M ago
CMPX
Compass Therapeutics price target lowered to $6 from $12 at Stifel
PremiumThe Fly
Compass Therapeutics price target lowered to $6 from $12 at Stifel
3M ago
CMPX
Compass Therapeutics selloff ‘an over-reaction,’ says Jefferies
PremiumThe Fly
Compass Therapeutics selloff ‘an over-reaction,’ says Jefferies
3M ago
CMPX
Leerink says Compass data supports path forward for tovecimig in 2L BTC
PremiumThe Fly
Leerink says Compass data supports path forward for tovecimig in 2L BTC
3M ago
CMPX
Midday Fly By: Verizon reports ‘beat and raise,’ Shell to acquire ARC
PremiumThe FlyMidday Fly By: Verizon reports ‘beat and raise,’ Shell to acquire ARC
3M ago
VZ
WW
Analyst Maintains Buy on Tovecimig Developer, Sees PFS Strength Underappreciated and Keeps $24 Price Target Unchanged
Premium
Ratings
Analyst Maintains Buy on Tovecimig Developer, Sees PFS Strength Underappreciated and Keeps $24 Price Target Unchanged
3M ago
CMPX
H.C. Wainwright keeps Buy rating on Compass Therapeutics after data
Premium
The Fly
H.C. Wainwright keeps Buy rating on Compass Therapeutics after data
3M ago
CMPX
Buy Rating Reiterated on Compass Therapeutics as Tovecimig Combo Shows Strong PFS Benefit but OS Signal Clouded by Crossover Effects
PremiumRatings
Buy Rating Reiterated on Compass Therapeutics as Tovecimig Combo Shows Strong PFS Benefit but OS Signal Clouded by Crossover Effects
3M ago
CMPX
Morning Movers: Domino’s Pizza sinks following first quarter results
PremiumThe Fly
Morning Movers: Domino’s Pizza sinks following first quarter results
3M ago
VZ
CPB
Compass Therapeutics Reports Positive Phase 2/3 BTC Results
PremiumCompany Announcements
Compass Therapeutics Reports Positive Phase 2/3 BTC Results
3M ago
8K
CMPX
Compass Therapeutics reports additional COMPANION-002 study results
PremiumThe Fly
Compass Therapeutics reports additional COMPANION-002 study results
3M ago
CMPX
Compass Therapeutics (CMPX): Favorable Risk‑Reward Ahead of Pivotal Tovecimig Data in Biliary Tract Cancer
PremiumRatingsCompass Therapeutics (CMPX): Favorable Risk‑Reward Ahead of Pivotal Tovecimig Data in Biliary Tract Cancer
4M ago
CMPX
Buy Rating on Compass Therapeutics: Anticipating Pivotal Tovecimig Data as a Key Value Inflection Point in Advanced Biliary Tract Cancer
Premium
Ratings
Buy Rating on Compass Therapeutics: Anticipating Pivotal Tovecimig Data as a Key Value Inflection Point in Advanced Biliary Tract Cancer
4M ago
CMPX
Compass Therapeutics reports Q4 EPS (9c), consensus (9c)
Premium
The Fly
Compass Therapeutics reports Q4 EPS (9c), consensus (9c)
5M ago
CMPX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >